Method of using quantitative analysis of multi-components by single marker for measuring contents of five components in corydalis saxicola bunting

Through one-test and multiple evaluation methods and high-performance liquid chromatography detection, dehydrogenated methylcarvedin is used as an internal reference substance, and the problems of fewer and high cost in the quality evaluation method of Yanhuanglian were solved, and the medicinal materials and total alkalis of Yanhuanglian were realized. , Accurate detection of five chemical components in total alkali capsules, simplifies operation, improves efficiency, and reduces costs, and is suitable for quality control of Yanhuanglian.

WO2024244097A1PCT designated stage expired Publication Date: 2024-12-05NANJING ZHONGSHAN PHARMA CO LTD +1
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2023/104523
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-29
Filing Date
2023-06-30
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

The existing quality evaluation methods of Yanhuang and its preparations have problems such as few detection components, many standard products, cumbersome operation steps, long analysis cycles and high cost, making it difficult to achieve stable and controllable, low cost, accurate and efficient quality control.

Method used

The first-test and multiple evaluation method (QAMS) was used to detect high performance liquid chromatography, and dehydrogenated methylcarvidine was used as an internal reference substance to establish a relative correction factor, calculate the content of five chemical components in Coptis chinensis, simplify operation, improve efficiency, and reduce cost.

Benefits of technology

It realizes accurate detection of five chemical components in Yanhuang medicinal materials, total alkali and total alkali capsules, saves costs, simplifies operations, improves efficiency, has high detection sensitivity, good stability, and has strong specificity and reproducibility. Suitable for the comprehensive quality control of Yanhuanglian.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2023104523_05122024_PF_FP_ABST
    Figure CN2023104523_05122024_PF_FP_ABST
Patent Text Reader

Abstract

A measuring method for dehydroapocavidine, dehydroisoapocavidine, dehydrocavidine, palmatine chloride, and berberine hydrochloride in Corydalis saxicola Bunting. The method comprises the following steps: step 1, preparing a reference solution; step 2, preparing a test solution; and 3, precisely suctioning the reference solution and the test solution, respectively, injecting the reference solution and the test solution into a liquid chromatograph, performing measurement by means of an ultraviolet visible light detector, and carrying out methodological investigation at the same time. By using the measuring method completed by the above-mentioned steps, the analysis is rapid and accurate, and has high specificity and good reproducibility and stability, an obtained chromatogram has a good chromatogram peak shape, and a certain reference can be provided for Corydalis saxicola Bunting content measurement.
Need to check novelty before this filing date? Find Prior Art

Description

A one-measurement, multiple-evaluation method for the determination of five chemical components in Coptis chinensis Technical Field

[0001] The invention relates to the field of analytical chemistry, and in particular to a one-test-multiple-evaluation content detection method for five chemical components in Coptis chinensis, which can be used for content determination of the five chemical components in Coptis chinensis, Coptis chinensis medicinal materials, and Coptis chinensis total alkaloid capsules. Background Art

[0002] Corydalis saxicola Bunting (CSB) is the whole herb of Corydalis saxicola Bunting, a plant of the genus Corydalis in the family Papaveraceae. It is primarily found in Guangxi, Guizhou, and Yunnan provinces of my country. It has the effects of clearing heat and detoxifying, promoting diuresis, relieving pain and stopping bleeding, and is currently a commonly used traditional Chinese medicine for the clinical treatment of hepatitis, liver fibrosis, and cirrhosis. The chemical components that exert the pharmacological effects of Corydalis saxicola Bunting are primarily alkaloids, collectively referred to as Corydalis saxicola Bunting total alkaloids (CSBTA). Modern pharmacological studies have shown that CSBTA has a wide range of pharmacological effects, including hepatoprotection, analgesia, anti-tumor, and antibacterial properties, and has broad prospects for development and application. Corydalis saxicola Bunting total alkaloid capsules have the effects of clearing heat and detoxifying, promoting diuresis, stopping pain and stopping bleeding, and are primarily used to treat non-alcoholic fatty liver disease, which is a syndrome of damp-heat accumulation, and acute and chronic hepatitis, which is a syndrome of damp-heat in the liver and gallbladder.

[0003] The quantitative analysis of multicomponents by single marker (QAMS) is a new model for simultaneous quality control of multiple components in traditional Chinese medicine (TCM). It refers to the use of the intrinsic functional and proportional relationships of the active ingredients of traditional Chinese medicine to achieve the simultaneous determination of multiple components (reference materials are difficult to obtain or supply) by measuring only one stable, inexpensive, and easily available component. It can effectively solve the problems of excessive use of reference materials, high cost, and difficulty in supply in the process of multi-indicator quality control of traditional Chinese medicine. This method will be the development direction of simultaneous quantification of multiple components in traditional Chinese medicine.

[0004] Currently reported quality evaluation methods for Coptis chinensis and its preparations suffer from issues such as a limited number of test components, a large variety of standard products, cumbersome procedures, long analysis cycles, and high costs. Therefore, this patent provides a new approach for establishing a stable, controllable, low-cost, accurate, and efficient quality control method for Coptis chinensis and its preparations.

[0005] Summary of the Invention

[0006] The purpose of the present invention is to use a one-test, multiple-evaluation method to detect the content of five monomer alkaloids in Coptis chinensis and its preparations. This detection method can objectively, comprehensively and accurately detect the content of dehydromethylcavitine, dehydroisoapocavitine, dehydrocavitine, bamipine hydrochloride and berberine hydrochloride, providing certain data reference for the quality research of Coptis chinensis and its preparations.

[0007] A one-step, multi-evaluation method for detecting the contents of five chemical components in Coptis chinensis, comprising the following steps:

[0008] S1: Prepare reference solution

[0009] Dissolve dehydromethylcavitin reference substance, dehydroisoapocavitin reference substance, dehydrocavitin reference substance, palmatine hydrochloride reference substance, and berberine hydrochloride reference substance in methanol to prepare a reference substance solution;

[0010] S2: Prepare the test solution

[0011] The test sample is selected from Coptis chinensis medicinal material, Coptis chinensis total alkaloids, and Coptis chinensis total alkaloids capsules;

[0012] When the test sample is Coptis chinensis, add 75% ethanol to the Coptis chinensis, perform ultrasonication, filter through a microporous filter membrane, and take the filtrate to obtain the product;

[0013] When the test sample is the total alkaloids of Coptis chinensis, add 75% ethanol to the total alkaloids of Coptis chinensis, perform ultrasonication, filter through a microporous filter membrane, and take the filtrate to obtain the product;

[0014] When the test sample is Coptis chinensis total alkaloid capsule, take the contents of Coptis chinensis total alkaloid capsule, add 1% hydrochloric acid methanol, ultrasonicate, filter through a microporous filter membrane, and take the filtrate to obtain;

[0015] S3: High-performance liquid chromatography

[0016] Accurately pipette the reference solution and the test solution separately, inject them into the liquid chromatograph, and calculate the content using the external standard method and QAMS method; the chromatographic conditions are:

[0017] Chromatographic column: Octadecylsilane bonded silica gel as filler;

[0018] Mobile phase: Mobile phase A is acetonitrile, mobile phase B is 0.01 mol / L potassium dihydrogen phosphate solution, gradient elution;

[0019] Detection wavelength: 345nm;

[0020] Column temperature: 30°C;

[0021] Flow rate: 0.8-1.2 mL / min, preferably, flow rate: 1 mL / min;

[0022] Injection volume: 10uL;

[0023] The number of theoretical plates calculated based on the dehydrocarvidine peak should be no less than 3000;

[0024] Gradient elution conditions were:

[0025] Table 1 Gradient elution conditions

[0026] Furthermore, the concentrations of dehydromethylcavitin, dehydroisoapocavitin, dehydrocavitin, palmatine hydrochloride, and berberine hydrochloride in the reference solution of S1 are 100 ug / mL, 40 ug / mL, 160 ug / mL, 100 ug / mL, and 20 ug / mL.

[0027] Furthermore, the ultrasound in S2 is performed at a power of 500W and a frequency of 40KHz for 15 minutes.

[0028] Furthermore, in S2, when the test sample is Coptis chinensis medicinal material, the concentration of the test sample solution is 4 mg / mL based on Coptis chinensis medicinal material;

[0029] Furthermore, in S2, when the test sample is the total alkaloids of Coptis chinensis, the concentration of the test sample solution is 0.5 mg / mL based on the total alkaloids of Coptis chinensis;

[0030] Furthermore, in S2, when the test sample is Coptis chinensis total alkaloid capsule, the concentration of the test sample solution is 1.4 mg / mL based on the contents of Coptis chinensis total alkaloid capsule. Beneficial effects

[0031] The single-test, multi-evaluation method for Coptis chinensis described in the present invention can be used to determine the contents of five chemical components in Coptis chinensis medicinal materials, Coptis chinensis total alkaloids, and Coptis chinensis total alkaloid capsules. The single-test, multi-evaluation method uses inexpensive and readily available dehydrocavidin as an internal reference substance. Relative retention times and relative correction factors are established between dehydrocavidin and dehydromethylcavidin, dehydroisoapocavidin, bamipine hydrochloride, and berberine hydrochloride. The contents of dehydromethylcavidin, dehydroisoapocavidin, dehydrocavidin, bamipine hydrochloride, and berberine hydrochloride in Coptis chinensis are calculated using the relative correction factors and determined using ultra-performance liquid chromatography.

[0032] The method of the present invention calculates the content of index components through relative correction factors and chromatographic peak positioning, and can simultaneously and effectively detect the contents of five components in Coptis chinensis, namely dehydromethylcavitin, dehydroisoapocavitin, dehydrocavitin, bamipine hydrochloride and berberine hydrochloride. It can save costs, simplify operations, and improve efficiency. The method has high detection sensitivity, good stability, and accurate and reliable measurement results, which is of great significance for quality control of Coptis chinensis and ensuring its clinical efficacy.

[0033] The sample detection method established by the present invention has the advantages of fast and accurate analysis, strong specificity, good reproducibility and stability. At the same time, based on high performance liquid chromatography technology, the obtained chromatogram has a good chromatographic peak shape. Combined with the one-measurement-multiple-evaluation method, the method is accurate and reliable, suitable for the content determination of multiple components in Coptis chinensis and its preparations, which is beneficial to the comprehensive quality control of Coptis chinensis. In addition, the method has high detection sensitivity, good stability, low cost, simple operation, easy to master, and convenient for further promotion. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 is a chromatogram of a mixed reference substance of Coptis chinensis;

[0035] Figure 2 is a chromatogram of a test sample of Coptis chinensis medicinal material;

[0036] Figure 3 is a chromatogram of a total alkaloid sample of Coptis chinensis;

[0037] Figure 4 is a chromatogram of a test sample of Coptis chinensis total alkaloid capsules;

[0038] Peaks 1 to 5 marked in the figure are: dehydromethylcavitin, dehydroisoapocavitin, dehydrocavitin, bamipine hydrochloride, and berberine hydrochloride, respectively. DETAILED DESCRIPTION

[0039] The present invention is further explained below with reference to the following examples, but the examples do not limit the present invention in any form.

[0040] The instruments and reagents used in the examples are as follows:

[0041] Instruments: Shimadzu high-performance liquid chromatograph, including a binary pump system LC-40D, a fully automatic sampling system SIL-40C, a UV-visible detector SPD-M40, and an automatic temperature-controlled column oven CTO-40S; ML104 / 02 electronic analytical balance (Mettler Toledo); XSR105DU / A electronic analytical balance (Mettler Toledo); and a KH-500E ultrasonic cleaner (Kunshan Hechuang Ultrasonic Instrument Co., Ltd.).

[0042] Test drugs: The sources of Rhizoma Coptidis samples are shown in Table 2; dehydromethylcavitin, dehydroisoapocavitin, dehydrocavitin, palmatine hydrochloride, and berberine hydrochloride were purchased from the China Food and Drug Inspection Institute; methanol (analytical grade); ethanol (analytical grade); acetonitrile (chromatographic grade); hydrochloric acid (analytical grade); and ultrapure water.

[0043] Table 2 Information of Rhizoma Coptis Chinensis Samples

[0044] Example 1 A method for determining the contents of five chemical components in Coptis chinensis and its preparations using a single assay and multiple evaluations comprises the following steps:

[0045] Step 1:

[0046] Preparation of reference solution: Weigh 5 mg of dehydromethylcavitin, 2 mg of dehydroisoapocavitin, 8 mg of dehydrocavitin, 5 mg of palmatine hydrochloride, and 1 mg of berberine hydrochloride, accurately weigh, place in a 50 mL volumetric flask, dissolve in methanol and make up to volume so that the concentrations of dehydromethylcavitin, dehydroisoapocavitin, dehydrocavitin, palmatine hydrochloride, and berberine hydrochloride are 100 ug / mL, 40 ug / mL, 160 ug / mL, 100 ug / mL, and 20 ug / mL respectively.

[0047] Step 2:

[0048] Preparation of the test solution of medicinal materials: Weigh 0.2 g of Coptis chinensis medicinal materials, accurately weigh it, place it in a stoppered conical flask, accurately add 50 mL of 75% ethanol, weigh it, ultrasonicate for 15 minutes (power 500 W, frequency 40 kHz), let it cool, make up the weight loss with 75% ethanol, shake it well, filter it with a microporous membrane (0.22 μm), and take the filtrate to obtain the solution.

[0049] Preparation of total alkali test solution: weigh 25 mg of total alkaloids of Coptis chinensis, accurately weigh, place in a stoppered conical flask, accurately add 50 mL of 75% ethanol, weigh the weight, ultrasonicate for 15 minutes (power 500 W, frequency 40 kHz), cool, make up the weight loss with 75% ethanol, shake well, filter with a microporous filter membrane (0.22 μm), and take the filtrate to obtain.

[0050] Preparation of capsule test solution: Weigh 70 mg of the contents of Coptis chinensis total alkaloids capsule, accurately weigh, place in a stoppered conical flask, accurately add 50 mL of 1% hydrochloric acid and methanol, weigh the weight, ultrasonicate for 15 minutes (power 500 W, frequency 40 kHz), cool, add 1% hydrochloric acid and methanol to make up the weight loss, shake well, filter with a microporous filter membrane (0.22 μm), and take the filtrate to obtain.

[0051] Step 3:

[0052] Accurately pipette 10 μL of the reference solution from step 1 and 9 batches of test solution from step 2 into a liquid chromatograph using octadecylsilane bonded silica gel as the filler; use acetonitrile (A)-0.01 mol / L potassium dihydrogen phosphate solution (B) as the mobile phase, and use a gradient elution method as shown in Table 3; the detection wavelength is 345 nm; the column temperature is 30°C, and the flow rate is 1 mL / min; the number of theoretical plates calculated based on the dehydrocarvidine peak should be no less than 3000.

[0053] Table 3 Gradient elution conditions

[0054] The chromatograms of the reference substance, Coptis chinensis medicinal material, Coptis chinensis total alkaloids, and Coptis chinensis total alkaloids capsule are shown in Figures 1 to 4, and the peaks 1-5 marked in the figures are: dehydromethylcavitin, dehydroisoapocavitin, dehydrocavitin, bamipine hydrochloride, and berberine hydrochloride, respectively.

[0055] The contents of dehydromethylcavitin, dehydroisoapocavitin, dehydrocavitin, palmatine hydrochloride and berberine hydrochloride in Coptis chinensis medicinal materials, total alkaloids and capsules were determined by external standard method and QAMS method, as shown in Table 4.

[0056] The results showed that there was no significant difference in the contents determined by the two methods.

[0057] Table 4 Contents of five compounds in Coptis chinensis medicinal materials, total alkaloids, and capsules

[0058] Example 2 Methodological Investigation

[0059] 1. Linear relationship investigation

[0060] Take the mixed reference solution and accurately pipette 1, 2, 4, 6, 8, and 10 ml into 10 ml volumetric flasks. Dose to volume with methanol to obtain the mixed reference solutions of Control 1-Control 6. Perform the assay under the same chromatographic conditions. Perform linear regression with the concentration of the reference solution as the X-axis and the chromatographic peak area as the Y-axis. The results of the linear relationship are shown in Table 5.

[0061] Table 5 Regression equations, linear ranges, and correlation coefficients of the five components

[0062] 2. Precision test

[0063] Accurately pipette 10 μl of the mixed reference solution (Control-3) and inject it six times continuously. The RSDs of the peak areas of the five components were calculated. The results showed that the RSDs of the peak areas of dehydromethylcavitin, dehydroisoapocavitin, dehydrocavitin, bamipine hydrochloride, and berberine hydrochloride were 0.24%, 0.21%, 0.25%, 0.27%, and 0.35%, respectively. All were less than 3%, indicating good instrument precision. (See Table 6 for details.)

[0064] 3. Stability test

[0065] The same test solution (medicinal material 210601, total alkali 200701, capsule 210301) was injected and analyzed at 0, 2, 4, 6, 8, 10, 12, and 24 hours, and the peak area of ​​each analyte was determined. The RSD of the peak area of ​​dehydromethylcavitin, dehydroisoapocavitin, dehydrocavitin, bamipine hydrochloride, and berberine hydrochloride were calculated to be 0.27%, 0.34%, 0.69%, 0.73%, 0.81%, 0.97%, 0.98%, 0.9 ... .29%, 0.32%, 0.42% (medicinal material 210601); 0.22%, 0.31%, 1.06%, 0.29%, 0.29% (total alkali 200701); 0.74%, 0.69%, 0.74%, 0.74%, 1.12% (capsule 210301), all less than 3%, indicating that the test solution is relatively stable within 24 hours, see Table 6 for details.

[0066] 4. Repeatability test

[0067] Six portions each of the same batch of Coptis chinensis (210601), Coptis chinensis total alkaloids (200701), and Coptis chinensis capsules (210301) were used to prepare test solutions using the same method and assayed under the same chromatographic conditions. The RSDs for dehydromethylcavitin, dehydroisoapocavitin, dehydrocavitin, palmatine hydrochloride, and berberine hydrochloride were 0.78%, 1.16%, 0.70%, 0.40%, and 0.65% (Crude Material 210601); 0.42%, 0.51%, 0.41%, 0.30%, and 0.60% (Total Alkali 200701); and 0.38%, 0.54%, 0.43%, 0.28%, and 0.38% (Capsule 210301), all less than 3%, indicating good reproducibility of the method. (See Table 6 for details.)

[0068] Table 6 Precision, stability and repeatability tests of five components

[0069] 5. Sample recovery test

[0070] Nine portions of powdered samples of Coptis chinensis medicinal material (210601), Coptis chinensis total alkaloids (200701), and Coptis chinensis total alkaloid capsules (210301) with known contents were taken, including about 0.1 g of medicinal material, about 12.5 mg of total alkaloids, and about 35 mg of capsules. They were accurately weighed and added with reference substances at three levels of 80%, 100%, and 120% of the known contents (0.8, 1.0, and 1.2 ml of mixed standard solution were added to the medicinal material sample recovery test; 0.8, 1.0, and 1.2 ml of mixed standard solution were added to the total alkaloid sample recovery test; 0.8, 1.0, and 1.2 ml of mixed standard solution were added to the capsule sample recovery test). Three samples were taken for each level. Sample solutions were prepared in the same way. Samples were injected and measured, and the sample recovery rates were calculated, as shown in Tables 7-9.

[0071] Table 7 Medicinal material sample recovery test results

[0072] Table 8 Total alkali recovery test results

[0073] Table 9 Capsule sample recovery test results

[0074] 6. Determination of relative correction factor

[0075] Take the mixed reference solution control 1 to control 6, and inject 10 μL of each concentration. Use dehydrocarvadine as the internal standard and follow the formula f k / m =f k / f m =W k ×A m / W m ×A k (Among them, A k is the peak area of ​​the reference substance, W k is the reference concentration, A m is the peak area of ​​other components m, W m =(m) / ... k / T m (where T k is the retention time of the reference, T m The relative retention time was calculated (where m is the retention time of other components m). The results are shown in Tables 10 and 11.

[0076] Table 10 Correction Factors

[0077] Table 11 Relative retention time

[0078] 7Relative correction factor (f k / m ) Durability evaluation

[0079] 7.1 Effects of different HPLC instruments and columns on f k / mThe mixed reference substance-3 solution was accurately aspirated and the determination was carried out under the same chromatographic conditions. The effects of different HPLC instruments (Shimadzu LC-40D, Agilent 1260 Ⅱ, Waters e-2695), different chromatographic columns (ZORBAX SB-C18, Waters CSH TM C18, Shimadzu Shim-pack GIST) k / m The results show that f k / m The durability is good when using different instruments and different chromatographic columns. See Table 12-Table 13 for details.

[0080] Table 12 Effects of different HPLC instruments on f k / m Impact

[0081] Table 13 Effects of different chromatographic columns on f k / m Impact

[0082] 7.2 Effect of different flow rates and column temperatures on f k / m The impact of value

[0083] The mixed reference substance-3 solution was accurately drawn and measured under the same chromatographic conditions. The effects of different flow rates (0.8, 1.0, 1.2 mL / min) and column temperatures (30°C, 35°C, 40°C) on the f k / m The results show that f k / m The durability is good at different flow rates and column temperatures. See Table 14-Table 15 for details.

[0084] Table 14 Effect of different flow rates on f k / m Impact

[0085] Table 15 Effect of different column temperatures on f k / m Impact

[0086] 8. Chromatographic peak positioning of the component to be tested

[0087] The chromatographic peaks of the test components were located using relative retention time, i.e., the ratio of the retention time between each test component and dehydrocarvidine. The reproducibility of the relative retention values ​​on high performance liquid chromatographs of different brands and chromatographic columns of different models was investigated, as well as the reproducibility of the relative retention values ​​at different flow rates and column temperatures. The results showed good reproducibility, as shown in Tables 16 to 19 for details.

[0088] Table 16 Effect of different HPLC instruments on t

[0089] Table 17 Effect of different chromatographic columns on t

[0090] Table 18 Effect of different flow rates on t

[0091] Table 19 Effect of different column temperatures on t

[0092] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present invention. These improvements and modifications should also be regarded as within the scope of protection of the present invention.

Claims

1. A one-measurement, multiple-evaluation method for the content of five chemical components in Coptis chinensis, characterized in that: The method comprises the following steps: S1: Prepare reference solution Dissolve dehydromethylcavitin reference substance, dehydroisoapocavitin reference substance, dehydrocavitin reference substance, palmatine hydrochloride reference substance, and berberine hydrochloride reference substance in methanol to prepare a reference substance solution; S2: Prepare the test solution The test sample is selected from Coptis chinensis medicinal material, Coptis chinensis total alkaloids, and Coptis chinensis total alkaloids capsules; When the test sample is Coptis chinensis, add 75% ethanol to the Coptis chinensis, perform ultrasonication, filter through a microporous filter membrane, and take the filtrate to obtain the product; When the test sample is the total alkaloids of Coptis chinensis, add 75% ethanol to the total alkaloids of Coptis chinensis, perform ultrasonication, filter through a microporous filter membrane, and take the filtrate to obtain the product; When the test sample is Coptis chinensis total alkaloid capsule, take the contents of Coptis chinensis total alkaloid capsule, add 1% hydrochloric acid methanol, ultrasonicate, filter through a microporous filter membrane, and take the filtrate to obtain; S3: High-performance liquid chromatography Accurately pipette the reference solution and the test solution separately, inject them into the liquid chromatograph, and calculate the content using the external standard method and QAMS method; the chromatographic conditions are: Chromatographic column: Octadecylsilane bonded silica gel as filler; Mobile phase: Mobile phase A is acetonitrile, mobile phase B is 0.01 mol / L potassium dihydrogen phosphate solution, gradient elution; Detection wavelength: 345nm; Column temperature: 30°C; Flow rate: 0.8-1.2 mL / min, preferably, flow rate: 1 mL / min; Injection volume: 10uL; The number of theoretical plates calculated based on the dehydrocarvedin peak should be no less than 3000; Gradient elution conditions were:

2. The detection method according to claim 1, wherein The concentrations of dehydromethylcavitin, dehydroisoapocavitin, dehydrocavitin, palmatine hydrochloride, and berberine hydrochloride in the reference solution of S1 are 100 ug / mL, 40 ug / mL, 160 ug / mL, 100 ug / mL, and 20 ug / mL.

3. The detection method according to claim 1, wherein The ultrasound in S2 is performed at a power of 500W and a frequency of 40KHz for 15 minutes.

4. The detection method according to claim 1, wherein In S2, when the test sample is the medicinal material Coptis chinensis, the concentration of the test sample solution based on the medicinal material Coptis chinensis is 4 mg / mL.

5. The detection method according to claim 1, wherein In S2, when the test sample is the total alkaloids of Coptis chinensis, the concentration of the test sample solution is 0.5 mg / mL based on the total alkaloids of Coptis chinensis.

6. The detection method according to claim 1, characterized in that In S2, when the test sample is Coptis chinensis total alkaloid capsule, the concentration of the test sample solution is 1.4 mg / mL based on the content of Coptis chinensis total alkaloid capsule.

Citation Information

Patent Citations

  • Quality test method for corydalis saxicola bunting total alkali

    CN103575849A

  • Quality detecting method of corydalis saxicola injection

    CN106290674A

  • Corydalis saxicola bunting fingerprint detection method

    CN116183751A

  • Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them

    US20070249650A1